Market Place
Sourcing Support
All News #Library
Biotech
Orion Pharma Launches TEADCO Ph 1B/2 Trial For ODM-212 Combo
23 Apr 2026 //
GLOBENEWSWIRE
Orion And CMI Partner For Martti Ahtisaari Peace Foundation
18 Mar 2026 //
PRESS RELEASE
Orion Pharma Launches Ph2 TEADES Trial of ODM-212 in MPM & EHE
08 Jan 2026 //
PRESS RELEASE
Orion, Abzena Secure Exclusive Commercial License For Antibody
24 Oct 2025 //
PRESS RELEASE
Orion, Glykos Extend Pact For Next-Gen ADC Development
17 Jun 2025 //
PRESS RELEASE
Orion Announces Agreement with Shilpa Medicare
23 May 2025 //
PRESS RELEASE
Orion To Open Biologics R&D Centre In Cambridge In 2025
10 Mar 2025 //
GLOBENEWSWIRE
Invenra, Orion Partner For Bispecific Antibody Cancer Therapy
30 Jan 2025 //
PRESS RELEASE
Abilita and Orion Announce Research Collab to Next-Gen Antibody
19 Dec 2024 //
PRESS RELEASE
Orion and Alligator Bio amend agreement 2 bispecific antibodies
20 Nov 2024 //
PRESS RELEASE
Orion & Alligator Bioscience Amend Bispecific Antibodies Agreement
19 Nov 2024 //
#N/A
Orion: BlackRock Disclosure Under Chapter 9 Section 10
25 Apr 2024 //
GLOBENEWSWIRE
Orion and Glykos announce research collaboration and licensing agreement
08 Jan 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.